Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report.

Narongroeknawin P, Danila MI, Humphreys LG Jr, Barasch A, Curtis JR.

Spec Care Dentist. 2010 Mar-Apr;30(2):77-82. doi: 10.1111/j.1754-4505.2009.00128.x. Review.

PMID:
20415805
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.

Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.

Clin Ther. 2007 Aug;29(8):1548-58. Review.

PMID:
17919538
[PubMed - indexed for MEDLINE]
3.

Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw: a case report and narrative review.

Thumbigere-Math V, Gopalakrishnan R, Michalowicz BS.

Northwest Dent. 2013 Jan-Feb;92(1):12-8. Review.

PMID:
23516715
[PubMed - indexed for MEDLINE]
4.

Is your knowledge up-to-date? Bisphosphonate-related osteonecrosis of the jaw.

Barrow SY.

Int J Dent Hyg. 2008 Nov;6(4):376-7. doi: 10.1111/j.1601-5037.2008.00342.x. No abstract available.

PMID:
19138190
[PubMed - indexed for MEDLINE]
5.

Teriparatide therapy for alendronate-associated osteonecrosis of the jaw.

Cheung A, Seeman E.

N Engl J Med. 2010 Dec 16;363(25):2473-4. doi: 10.1056/NEJMc1002684. Epub 2010 Oct 16. No abstract available.

PMID:
20950167
[PubMed - indexed for MEDLINE]
Free Article
6.

Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report.

Wang HL, Weber D, McCauley LK.

J Periodontol. 2007 Mar;78(3):584-94. Review.

PMID:
17335384
[PubMed - indexed for MEDLINE]
7.

Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure.

Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez G, Silver P, Chandra M, McCloskey CA, Staffa JA, Willy M, Selby JV, Go AS; Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) Investigators.

J Oral Maxillofac Surg. 2010 Feb;68(2):243-53. doi: 10.1016/j.joms.2009.03.050. Epub 2009 Sep 24.

PMID:
19772941
[PubMed - indexed for MEDLINE]
8.

Teriparatide therapy for osteonecrosis of the jaw.

Chtioui H, Lamine F, Daghfous R.

N Engl J Med. 2011 Mar 17;364(11):1081-2; author reply 1082. doi: 10.1056/NEJMc1100730#SA1. No abstract available.

PMID:
21410382
[PubMed - indexed for MEDLINE]
9.

Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.

Hoefert S, Schmitz I, Tannapfel A, Eufinger H.

Clin Oral Investig. 2010 Jun;14(3):271-84. doi: 10.1007/s00784-009-0300-6. Epub 2009 Jun 18.

PMID:
19536569
[PubMed - indexed for MEDLINE]
10.

Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.

Kunchur R, Need A, Hughes T, Goss A.

J Oral Maxillofac Surg. 2009 Jun;67(6):1167-73. doi: 10.1016/j.joms.2009.02.004.

PMID:
19446200
[PubMed - indexed for MEDLINE]
11.

Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)].

Harper RP, Fung E.

J Oral Maxillofac Surg. 2007 Mar;65(3):573-80. No abstract available. Erratum in: J Oral Maxillofac Surg. 2007 May;65(5):1059. Dosage error in article text.

PMID:
17307613
[PubMed - indexed for MEDLINE]
12.

Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review.

Crépin S, Laroche ML, Sarry B, Merle L.

Eur J Clin Pharmacol. 2010 Jun;66(6):547-54. doi: 10.1007/s00228-010-0822-5. Epub 2010 May 1. Review.

PMID:
20437036
[PubMed - indexed for MEDLINE]
13.

[Osteonecrosis of the jaw developing during bisphosphonate treatment].

Udvardy E, Redl P, Márton I.

Magy Onkol. 2008 Mar;52(1):81-7. doi: 10.1556/MOnkol.52.2008.1.12. Review. Hungarian.

PMID:
18403302
[PubMed - indexed for MEDLINE]
14.

Teriparatide for bone loss in the jaw.

Grey A.

N Engl J Med. 2010 Dec 16;363(25):2458-9. doi: 10.1056/NEJMe1010459. Epub 2010 Oct 16. No abstract available.

PMID:
20950165
[PubMed - indexed for MEDLINE]
15.

Bisphosphonates and osteonecrosis of the jaw: a retrospective study.

Murad OM, Arora S, Farag AF, Guber HA.

Endocr Pract. 2007 May-Jun;13(3):232-8.

PMID:
17599853
[PubMed - indexed for MEDLINE]
16.

Teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw in an elderly Japanese woman with severe osteoporosis.

Iwamoto J, Yago K, Sato Y, Matsumoto H.

Clin Drug Investig. 2012 Aug 1;32(8):547-53. doi: 10.2165/11634430-000000000-00000.

PMID:
22734599
[PubMed - indexed for MEDLINE]
17.

Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.

Ersan N, van Ruijven LJ, Bronckers AL, Olgaç V, Ilgüy D, Everts V.

Dentomaxillofac Radiol. 2014;43(1):20130144. doi: 10.1259/dmfr.20130144. Epub 2013 Oct 29.

PMID:
24170800
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

More on the resolution of bisphosphonate-associated osteonecrosis of the jaw.

Tsai KY, Huang CS, Huang GM, Yu CT.

J Rheumatol. 2010 Mar;37(3):675; author reply 676. doi: 10.3899/jrheum.091022. No abstract available.

PMID:
20197569
[PubMed - indexed for MEDLINE]
19.

Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

Mavrokokki T, Cheng A, Stein B, Goss A.

J Oral Maxillofac Surg. 2007 Mar;65(3):415-23.

PMID:
17307586
[PubMed - indexed for MEDLINE]
20.

Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.

O'Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D, Martin D, Liberty D, Lo JC.

J Oral Maxillofac Surg. 2009 Jul;67(7):1363-72. doi: 10.1016/j.joms.2009.03.005.

PMID:
19531404
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk